Now in its 33rd year, the PDA/FDA Joint Regulatory Conference 2024 will offer a comprehensive agenda with substantive sessions and practical case studies that will provide insight into the everyday application of Current Good Manufacturing Practice (CGMP) and methodologies. Concurrent sessions will focus on topics related to practices and innovations, quality systems, and supply chains. The conference continues to be the essential annual CGMP event to attend and receive live and highly relevant Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Veterinary Medicine (CVM), and Office of Regulatory Affairs (ORA) updates.